The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / October / DNA Doesn't Have to Die with Us
Genetics and epigenetics Profession Opinion and Personal Narratives Professional Development Voices in the Community

DNA Doesn’t Have to Die with Us

A pathologist's reflections on legacy, mutation, and protecting the integrity of the human genome

By Nishit Kumar Gupta 10/08/2026 Opinion 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

Clinical Scorecard: DNA Doesn’t Have to Die with Us

At a Glance

CategoryDetail
ConditionGenetic mutations and their relationship to cancer, apoptosis, and inherited genetic variation
Key MechanismsMutations can compromise protein production and DNA repair. Oncogenes can drive abnormal growth, while tumor suppressor genes regulate the cell cycle, cell division, and apoptosis.
Target PopulationPeople and future generations affected by inherited or acquired genetic variation
Care SettingGeneral discussion of genetics, cancer biology, and public health; no specific clinical care setting is described

Key Highlights

  • Genetic mutations are part of human biology, and the author states that certain inherited mutations can pass from one generation to the next.
  • Apoptosis is described as the body’s mechanism of programmed cell death; the author says its malfunction is especially important to consider.
  • The article states that mutations compromising protein production and DNA repair are associated with most cancers.
  • The article identifies oncogenes, altered forms of normal genes that drive abnormal growth, and tumor suppressor genes, which govern the cell cycle, division, and apoptosis.
  • The author calls for reducing exposure to environmental mutagens, adopting healthier lifestyles, detecting genetic risk early, and guiding efforts with ethics, safety, equity, and respect for human diversity.

Guideline-Based Recommendations

Diagnosis

  • The author advocates detecting genetic risk early but does not specify diagnostic tests or criteria.

Management

  • The author calls for understanding and managing genetic mutations and, where possible, preventing transmission of unwanted genetic variation; this is an expressed aim, not a specified clinical intervention.
  • The author calls for reducing exposure to environmental mutagens and adopting healthier lifestyles.

Monitoring & Follow-up

  • No specific monitoring approach or schedule is provided.

Risks

  • The article identifies chemicals, viruses, and ionizing radiation as threats to cells.
  • It states that mutations compromising protein production and DNA repair are associated with most cancers.
  • It notes that certain inherited mutations can pass between generations.

Patient & Prescribing Data

No specific patient group or prescribing population is defined.

No medications, treatment regimens, or prescribing data are provided.

Clinical Best Practices

  • The author advocates early detection of genetic risk but provides no specific methods.
  • The author says efforts should be guided by ethics, safety, equity, and respect for human diversity.
  • The article describes mutation as both a potential source of disease and an engine of growth and evolution.

Related Resources & Content

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Nishit Kumar Gupta

Nishit Kumar Gupta, MD is Director, Nishit Clinical Laboratory, Paschim Vihar, New Delhi, India.

More Articles by Nishit Kumar Gupta

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.